# Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Inspection Records

Source: https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/05d2049f-ed44-40ae-8643-f957dc3c15f9

> Inspection records and compliance data for Wyeth Pharmaceutical Division of Wyeth Holdings LLC in Sanford, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- FEI Number: 1000110954
- City: Sanford
- State: North Carolina
- Country Name: United States
- Address Line 1: 4300 Oak Park Rd
- Zip Code: 27330

## Related Documents

- [483 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Unknown Date](https://www.keypedia.com/records/483/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/101b2bfd-2277-4fc2-9114-49c8354e84d4) — source: FDA, date: Invalid Date
- [FDA Inspection 1305396 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2026-04-23](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/8622ccae-d872-4af7-996d-78d1d5ad2ba5) — source: FDA, date: April 23, 2026
- [FDA Inspection 1305396 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2026-04-23](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/82c91522-3112-4d39-af5e-008f4aed37fa) — source: FDA, date: April 23, 2026
- [483 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2024-10-17](https://www.keypedia.com/records/483/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/47e17b26-1ded-497c-b42f-74e591b7455a) — source: FDA, date: October 17, 2024
- [FDA Inspection 1252280 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2024-10-17](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/8edcf3d1-8ada-4d4b-a7da-57756242fc94) — source: FDA, date: October 17, 2024
- [FDA Inspection 1252280 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2024-10-17](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/a198eeed-3026-465d-bf88-7793accbd962) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 17, 2024
- [FDA Inspection 1252280 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2024-10-17](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/7b3be29c-c433-4010-927a-0fee9f1bb8df) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 17, 2024
- [483 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2023-11-10](https://www.keypedia.com/records/483/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/0ba1c74f-85e2-4a5f-b9df-a2f55c5a93ad) — source: FDA, date: November 10, 2023
- [FDA Inspection 1234989 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2023-11-10](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/adad7266-ac20-4978-a2d1-29feeeea8139) — source: FDA, date: November 10, 2023
- [483 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2022-11-18](https://www.keypedia.com/records/483/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/b2f02d0f-7174-4554-bf3b-9d9454e9ebe6) — source: FDA, date: November 18, 2022
- [FDA Inspection 1192736 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2022-11-18](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/32e65aef-35d4-4b30-8645-ae761aaa7075) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 18, 2022
- [EIR - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2019-11-26](https://www.keypedia.com/records/eir/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/8116be41-5c38-4141-91ec-42ab8f1ada0b) — source: FDA, date: November 26, 2019
- [FDA Inspection 1121288 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2019-11-26](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/fc8b09d6-fb91-4f61-8718-5c18849c018c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 26, 2019
- [FDA Inspection 1051716 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2018-04-19](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/277e2e29-db7e-420f-b95d-b8fe933f6387) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 19, 2018
- [FDA Inspection 989301 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - 2016-08-18](https://www.keypedia.com/records/fda_inspections/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/e91dd217-6753-4501-a7ca-785b532c82f4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 18, 2016

## Related Companies

- [Quality Chemical Laboratories](https://www.keypedia.com/companies/quality-chemical-laboratories/57f7f773-23e6-4d97-9621-b65592c11e62)
- [Pfizer Ireland Pharmaceuticals Unlimited Company](https://www.keypedia.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/095513de-fb4d-4c57-847c-bef3a3b235f4)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/7b05f5f2-461b-4a95-bfaa-a8c773250712)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/7d8d0f1a-2012-47a6-99c8-10c2953c39af)
- [Adare Pharmaceuticals, Inc.](https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5)
- [EUGIA Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/c9c73721-7ca2-4457-89c9-f1001123e141)
- [NerPharMa S.r.l.](https://www.keypedia.com/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391)
- [Apothecon Pharmaceuticals Private Limited](https://www.keypedia.com/companies/apothecon-pharmaceuticals-private-limited/9fd69fd5-d0ef-458e-bdf3-b9b73b75f954)
- [Merck Sharp & Dohme LLC](https://www.keypedia.com/companies/merck-sharp-dohme-llc/842c6e25-ee89-453c-a5b0-6b039c187744)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)

## Related Officers

- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [investigator](https://www.keypedia.com/people/brantley-s-collins/c806aac1-3d89-4427-8aeb-6d9db6dfc2f4)
- [issuing_officer](https://www.keypedia.com/people/scott-e-norris/8093919d-6e81-4629-8715-5e78be5c953a)
- [Lewis Autwi](https://www.keypedia.com/people/lewis-autwi/7c0a9d04-adfe-4c90-b29f-7bc8245c76cc)
- [Barrell M. Henry](https://www.keypedia.com/people/barrell-m-henry/7add7a21-8776-4fdf-8ecb-13c66cc6f8fe)